Press Releases
Endo Pharmaceuticals Announces That FDA Eliminates Need for Advisory...
 Endo Pharmaceuticals announced that the U.S. FDA has informed the company that FDA no longer sees a need to convene a joint meeting of...
Press Releases
Abbott Wins Two Scrip Awards Recognizing Excellence in Pharmaceutical...
Abbott Park, Illinois Scrip, a leading global pharmaceutical and biotech news organization, honored Abbott with two 2010 Scrip Awards for its business excellence and strong...
Press Releases
Nycomed to acquire of majority stake in Guangdong Techpool...
Nycomed announced that it is significantly expanding its presence in China through the acquisition of a majority stake in Guangdong Techpool Bio-Pharma Co., Ltd. (Techpool),...
Press Releases
PTC Therapeutics Initiates Phase 2 Clinical Trial of Ataluren...
PTC Therapeutics, Inc. today announced that it is expanding the development of ataluren, an investigational new drug, with the initiation of a Phase 2 clinical...
Press Releases
Celator Pharmaceuticals completes enrollment in a second phase 2...
Celator Pharmaceuticals announced that it has completed enrollment in a phase 2 multicenter, randomized, open-label clinical trial of CPX-351 (Cytarabine:Daunorubicin) Liposome Injection versus intensive salvage...
Press Releases
Eurand Presents Data on ZENPEP(R) Without Proton Pump Inhibitors...
Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V. announced additional data from a post-hoc analysis of a Phase III clinical trial...
Press Releases
Cephalon Announces FDA Approval of Risk Evaluation and Mitigation...
Cephalon, Inc. (Nasdaq: CEPH) today announced that Risk Evaluation and Mitigation Strategies (REMS) for its medications NUVIGIL(R) (armodafinil) Tablets and PROVIGIL(R) (modafinil) Tablets ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.